1.上海交通大学医学院附属瑞金医院中医科(上海 200025)
2.上海交通大学医学院附属瑞金医院骨科(上海 200025)
3.上海交通大学医学院附属瑞金医院临床营养科(上海 200025)
扫 描 看 全 文
王洁,阮铭,庄澄宇等.加味五子衍宗丸基于视黄素X受体表达防治ApoE-/-小鼠骨质疏松的作用机制研究[J].上海中医药大学学报,2022,36(06):70-75.
WANG Jie,RUAN Ming,ZHUANG Chengyu,et al.Mechanism study of modified Wuzi Yanzong Pill on prevention and treatment of osteoporosis in ApoE-/- mice based on retinoid X receptor expression[J].Academic Journal of Shanghai University of Traditional Chinese Medicine,2022,36(06):70-75.
王洁,阮铭,庄澄宇等.加味五子衍宗丸基于视黄素X受体表达防治ApoE-/-小鼠骨质疏松的作用机制研究[J].上海中医药大学学报,2022,36(06):70-75. DOI: 10.16306/j.1008-861x.2022.06.011.
WANG Jie,RUAN Ming,ZHUANG Chengyu,et al.Mechanism study of modified Wuzi Yanzong Pill on prevention and treatment of osteoporosis in ApoE-/- mice based on retinoid X receptor expression[J].Academic Journal of Shanghai University of Traditional Chinese Medicine,2022,36(06):70-75. DOI: 10.16306/j.1008-861x.2022.06.011.
目的,2,探讨加味五子衍宗丸防治载脂蛋白E敲除(ApoE,-/-,)小鼠骨质疏松的相关作用机制。,方法,2,8周龄ApoE,-/-,小鼠随机分为阴性对照组、模型组、治疗组和阳性对照组,每组6只。阴性对照组和模型组小鼠给予常规饲料;治疗组和阳性对照组小鼠给予高脂饲料,同时分别灌胃给予加味五子衍宗丸和阿仑膦酸钠悬液。各组小鼠连续干预24周后,取股骨做微型电子计算机断层扫描(Micro CT)、HE染色、Trap染色及免疫组化染色,观察各组小鼠骨质疏松情况、破骨细胞数量及视黄素X受体(RXR)的表达情况。,结果,2,①与阴性对照组比较,模型组小鼠股骨Micro CT检测指标骨密度(BMD)、骨体积分数(BV/TV)、骨小梁厚度(Tb.Th)和骨小梁数量(Tb.N)均显著下降(,P,<,0.05);与模型组相比,治疗组的BMD、BV/TV、Tb.Th、Tb.N均显著增加(,P,<,0.05)。②与阴性对照组比较,模型组骨质疏松面积显著增加(,P,<,0.01);与模型组比较,治疗组及阳性对照组骨质疏松面积显著减少(,P,<,0.01)。③模型组破骨细胞数量显著高于阴性对照组(,P,<,0.01),治疗组和阳性对照组破骨细胞数量则显著低于模型组(,P,<,0.01)。④与阴性对照组比较,模型组小鼠RXRα和RXRβ蛋白表达显著增加(,P,<,0.01);与模型组比较,治疗组和阳性对照组小鼠RXRα和RXRβ蛋白表达显著减少(,P,<,0.01)。,结论,2,加味五子衍宗丸可抑制ApoE,-/-,小鼠股骨骨质疏松的进展,其作用机制可能与抑制RXR的表达及破骨细胞增殖有关。
Objective: To investigate the related mechanism of modified Wuzi Yanzong Pill on prevention and treatment of osteoporosis in apolipoprotein E knockout(ApoE,-/-,) mice.,Methods,2,The 8-week-old ApoE,-/-, mice were randomly divided into negative control group, model group, treatment group and positive control group, with 6 mice in each group. The mice in negative control group and model group were fed with normal diet. The mice in treatment group and positive control group were fed with high fat diet, supplemented with modified Wuzi Yanzong Pill and alendronate sodium by gavage respectively. After 24 weeks of continuous intervention, femurs of mice in each group were taken for micro computed tomography (Micro CT), HE staining, Trap staining and immumohistochemical staining to observe the status of osteoporosis, the number of osteoclasts and the expression of retinoid X receptor (RXR) in each group.,Results,2,①Compared with the negative control group, femur Micro CT detection indexes of bone mineral density (BMD), bone volume fraction (BV/TV), trabecular thickness (Tb.Th) and trabecular number (Tb.N) in model group were significantly decreased (,P,<,0.05). Compared with the model group, BMD, BV/TV, Tb.Th and Tb.N in treatment group were significantly increased (,P,<,0.05). ②Compared with the negative control group, the osteoporosis area in the model group was significantly increased (,P,<,0.01). Compare with the model group, the area of osteoporosis in the treatment group and the positive control group was significantly decreased (,P,<,0.01). ③The numbers of osteoclasts in the model group were significantly higher than that in the negative control group (,P,<,0.01), while the number of osteoclasts in the treatment group and positive control group was significantly lower than that in the model group(,P,<,0.01). ④Compared with the negative control group, the expression of RXRα and RXRβ protein in the model group was significantly increased (,P,<,0.01); Compared with the model group, the expression of RXRα and RXRβ protein in the treatment group and positive control group was significantly decreased (,P,<,0.01).,Conclusion,2,Modified Wuzi Yanzong Pill could inhibit the progression of femur osteoporosis in ApoE,-/-,mice, and the mechanism may be related to the inhibition of RXR expression and osteoclast proliferation.
加味五子衍宗丸骨质疏松ApoE-/-小鼠高脂饮食视黄素X受体
modified Wuzi Yanzong PillosteoporosisApoE-/- micehigh fat dietretinoid X receptor
REID IAN R. A broader strategy for osteoporosis interventions[J]. Nat Rev Endocrinol, 2020, 16(6): 333-339.
BLACK D M,ROSEN C J. Clinical Practice. Postmenopausal Osteoporosis[J]. N Engl J Med, 2016, 374(3): 254-262.
LESLIE W D, CRANDALL C J. Serial Bone Density Measurement for Osteoporosis Screening[J]. JAMA, 2021, 326(16): 1622-1623.
梁帅,曲华,凌树宽,等. 中药防治骨质疏松症的研究进展[J]. 北京中医药,2021, 40(10): 1169-1173.
KYLMAOJA E, NAKAMURA M, TUUKKANEN J. Osteoclasts and Remodeling Based Bone Formation[J]. Curr Stem Cell Res Ther, 2016, 11(8): 626-633.
CHEN X, WANG Z Q, DUAN N, et al. Osteoblast-osteoclast interactions[J]. Connect Tissue Res, 2018, 59(2): 99-107.
GARDNER C R. Comparison of morphological effects of PGE2 and TGFbeta on osteoclastogenesis induced by RANKL in mouse bone marrow cell cultures[J]. Cell Tissue Res, 2007, 330(1): 111-121.
KIM J M, LIN C, STAVRE Z, et al. Osteoblast-Osteoclast Communication and Bone Homeostasis[J]. Cells, 2020, 9(9): 2073.
LOI F, CORDOVE L A, PAJARINEN J, et al. Inflammation, fracture and bone repair[J]. Bone, 2016, 86: 119-130.
MENENDEZ M P, RICOTE M. The multi-faceted role of retinoid X receptor in bone remodeling[J]. Cell Mol Life Sci, 2017, 74(12): 2135-2149.
MENENDEZ M P, ROSEZER T, FUENTES L, et al. Retinoid X receptors orchestrate osteoclast differentiation and postnatal bone remodeling[J]. J Clin Invest, 2015, 125(2): 809-823.
燕云.中医药防治骨质疏松症临床研究进展[J]. 中国中医药信息杂志,2004, 11(10): 931.
HUO J,SUN X. Effect of Astragalus polysaccharides on ovariectomy-induced osteoporosis in mice[J/OL]. Genet Mol Res,2016[2022-7-13]. https://pubmed.ncbi.nlm.nih.gov/28002602/https://pubmed.ncbi.nlm.nih.gov/28002602/.
HONG W, XU X Y, QIU Z H, et al. Sirt1 is involved in decreased bone formation in aged apolipoprotein E-deficient mice[J]. Acta Pharmacol Sin, 2015, 36(12): 1487-1496.
林少煌. 少弱精症男性应用加味五子衍宗汤治疗的临床效果分析[J]. 黑龙江中医药,2019, 48(6): 6-7.
黄小容,周绍华,司维. 中西医结合治疗卒中后认知障碍41例临床研究[J]. 江苏中医药,2019, 51(6): 34-36.
王学华,史同霞. 五子衍宗丸的药理研究及临床应用进展[J]. 中央民族大学学报(自然科学版),2018, 27(2): 54-57.
徐波,卢进宝. 加味五子衍宗汤治疗骨质疏松50例[J]. 中原医刊,2000, 27(12): 60-61.
0
Views
172
下载量
0
CSCD
0
CNKI被引量
Publicity Resources
Related Articles
Related Author
Related Institution